Real-time enrollment status for this advanced melanoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:33 AM UTC
| NCT Number | NCT06940739 |
| Recruiting Status | Recruiting |
| Condition | Advanced Melanoma |
| Phase | Clinical Trial |
| Target Enrollment | 42 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Iovance Biotherapeutics, Inc. |
| Last Updated on CT.gov | December 3, 2025 (Dec 3, 2025) |
As of March 2, 2026: Clinical trial NCT06940739 is currently recruiting participants. This clinical trial study for advanced melanoma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Iovance Biotherapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06940739 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06940739 was last updated Dec 3, 2025 (December 3, 2025). HelloStudys verifies this status automatically.